GC3110A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GC3110A, covering 2017-05-30 to 2017-09-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age [Phase 3]